Approvals/TGA/BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial

Approved

STANDARD

BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial

Accelagen Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: a451c230caf1f794
Product Name: BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial
Artg Id: 453648
Artg Name: BRIUMVI ublituximab 150 mg/6 mL concentrated injection for infusion vial
Sponsor: Accelagen Pty Ltd
Company Detail Path: /organization/accelagen-pty-ltd
Artg Date: 2025-06-11
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2cde47e749e26c9d495480f584743c71.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/6f2261e832d9c9c4762ab03056afea37.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

a451c230caf1f794

Type

Standard